BOULDER — Brickell Biotech Inc. (Nasdaq: BBI) received notice from the stock market Tuesday that it faces delisting for remaining in violation of the bid price rule, the company announced … Continued
Source: BizWest
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
Realtors tend to view a housing inventory of six to seven months’ supply as a market that’s balanced between buyers…
BOULDER — Brickell Biotech Inc. (Nasdaq: BBI), a clinical-stage pharmaceutical company, has launched a new brand, logo and website as…
BOULDER — Brickell Biotech Inc. (Nasdaq: BBI) received a notice last week that it faces delisting from the stock exchange…
BOULDER – Auddia Inc. (Nasdaq: AUDD), a Boulder-based audio and podcast technology company, has filed with the Securities and Exchange…
